Click here to read the full article.
A 2021 study of military youth has revealed that not only were minors with severe mental illness allowed to embark upon experimental medical sex changes, but also that prescriptions for anti-psychotic drugs actually increased after hormonal interventions were initiated, reports Fox News.
The study, published in the Journal of Sexual Medicine, examined the Department of Defense (DoD) medical records of 3,754 trans-identified adolescents and 6,603 siblings who did not identify as transgender. The findings reveal no improvement in mental health after commencing hormone interventions and an increase in prescriptions for psychotropic medication.
“Among 963 [transgender/gender diverse] youth using gender-affirming pharmaceuticals, mental healthcare did not significantly change and psychotropic medications increased following gender-affirming pharmaceutical initiation; older age was associated with decreased care and prescriptions,” reads the study.
The trans-identified cohort were more likely to have a mental health diagnosis, use more mental healthcare services, and be prescribed more psychotropic medications compared to the sibling cohort.
“The most pronounced increases in mental healthcare were for adjustment, anxiety, mood, personality, psychotic disorders, and suicidal ideation/attempted suicide,” the study noted. “The most pronounced increased in psychotropic medication were in SNRIs, sleep medications, anti-psychotics and lithium.”
Continue reading here.
Scroll down for comments and share your thoughts!
GIPHY App Key not set. Please check settings